Stark County Safety Council Presentation: Opioid & Anti-Anxiety Medication Use Among Ohio s Injured Workers

Size: px
Start display at page:

Download "Stark County Safety Council Presentation: Opioid & Anti-Anxiety Medication Use Among Ohio s Injured Workers"

Transcription

1 Stark County Safety Council Presentation: Opioid & Anti-Anxiety Medication Use Among Ohio s Injured Workers June 11, 2015 John Hanna, R.Ph. BWC, Pharmacy Director 6/24/2015 BWC Pharmacy Program Overview 1

2 Discussion Overview The BWC Pharmacy Program & Mission How the Mission is Accomplished Impact on Drug Utilization Impact on Opioids Mission Focus Going Forward 6/24/2015 BWC Pharmacy Program Overview 2

3 The BWC Pharmacy Program 2014 vs ,022 Injured Workers received an Rx (-26%) 990,369 Prescriptions covered (-36%) $113.4M total prescription cost (-16%) Average Unit cost/rx = $ (+8.2%) Average Rx Cost/Injured Worker=$2, (+13.7%) Generic Dispensing Rate = 83.4% (+4.8% vs 13) Each 1% Increase in GDR = $3.35M cost savings 6/24/2015 BWC Pharmacy Program Overview 3

4 The Pharmacy Program Mission Manage drug utilization to ensure coverage for necessary medications to allow proper care of injured workers in a fiscally responsible manner. 6/24/2015 BWC Pharmacy Program Overview 4

5 The Pharmacy Tools Formulary Relatedness Drugs & Prior Authorization Requirements Drug Utilization Reviews 6/24/2015 BWC Pharmacy Program Overview 5

6 Formulary Impact: Drug Utilization 2014 vs 2010 o24% fewer Injured workers received opioids o Opioid prescriptions (-38%) o 48% fewer Injured workers received muscle relaxants o Muscle relaxant prescriptions (-72%) o 79% fewer injured workers received anti-ulcer drugs o Anti-Ulcer prescriptions (-83%) 6/24/2015 BWC Pharmacy Program Overview 6

7 Formulary Impact: Drug Costs 2014 vs 2010 Total drug costs: -$22.8 million (-16.8%) o Opioids: -$19.9 million (-36%) o Muscle relaxants: -$2.8 million (-78%) o Anti-ulcer drugs: -$6.4 million (-95%) 6/24/2015 BWC Pharmacy Program Overview 7

8 Automated Rx Edits: Relatedness List Drugs In 2014 Automated Edits Applied in the pharmacy on all Rxs Stopped initial coverage of 235,000 Rxs Relatedness List Edits May require a PA Apply to 373 of 405 drug classes Matches drug indication & allowed conditions 3900 PAs processed by the PBM Pharmacists 4400 PAs processed by BWC staff 6/24/2015 BWC Pharmacy Program Overview 8

9 Automated Rx Edits: Formulary & Special Claim Edits Rxs for certain formulary drugs require a PA SR Opioids, Muscle Relaxants, Testosterone Some require an allowance Fentora, Lidoderm,Suboxone Special Claims Edits Medical Only Claims All require a PA after 60days from DOI Claims with no prescriptions for 270 days Require a PA for any prescription 6/24/2015 BWC Pharmacy Program Overview 9

10 Drug Utilization Reviews 2014 BWC-MCO Workgroup Recommendation Transition this activity to the MCOs DUR workgroup began work in June New process developed Pilot of new process began in November 2014 Transition to all MCO s 7/1/ DURs performed by BWC/MCOs in DURs performed by MCOs in /24/2015 BWC Pharmacy Program Overview 10

11 Injured Workers Receiving Medications 2001 to , ,000 98,352 97,337 95,539 97,286 90,000 91,376 87,178 82,331 All injured workers receiving prescriptions 80,000 75,109 70,000 60,000 50,000 40,000 30,000 56,889 63,602 65,881 68,825 69,858 66,611 67,406 63,937 65,338 60,923 60,821 55,115 56,398 51,712 49,957 50,211 47,680 43,140 39,427 Injured workers receiving opioids 34,458 20, /24/2015 BWC Pharmacy Program Overview 11

12 80% Injured Workers Receiving Opioids % 73% 73% 74% 73% 74% 74% 73% 70% 69% 71% 71% 70% 69% 65% 65% 60% 58% 55% 50% /24/2015 BWC Pharmacy Program Overview 12

13 Opioid Utilization Opioid doses per injured worker receiving opioids /24/2015 BWC Pharmacy Program Overview 13

14 Opioid Utilization Annual opiate load per injured worker receiving opioids (Mg MED/IW) /24/2015 BWC Pharmacy Program Overview 14

15 BWC Opiate Utilization 2010 vs o BWC s opiate dependency guideline: 60mg MED/Day for 60 days o In fourth quarter ,689 injured workers received this dose of opiates 13% of all injured workers receiving medications in 2010 were opiate dependent. 17% of injured workers receiving opioids o In fourth quarter 2014: 5,469 injured workers met it; 11% of all injured workers receiving medications. 16% of injured workers receiving opioids 6/24/2015 BWC Pharmacy Program Overview 15

16 Top 10 Highest Opiate Prescribers 2010 vs High dose opiate prescribers - 4th quarter 2010 High dose opiate prescribers - 4th quarter 2014 Prescriber Patients with total Mg MED/day > 399 Patients with total Mg MED/day Patients with total Mg MED/day Patients with total Mg MED/day > 999 Prescriber Patients with total Mg MED/day > 399 Patients with total Mg MED/day Patients with total Mg MED/day Patients with total Mg MED/day > 999 Dr. A Dr. B Dr. C Dr. D* Dr. E* Dr. F Dr. J* Dr. H 9 9 Dr. I Dr. J* 8 8 Dr. B Dr. K** Dr. L Dr. M Dr. N Dr. O 6 6 Dr. P Dr. Q Dr. A** Dr. W 5 5 6/24/2015 BWC Pharmacy Program Overview 16

17 Acute to Chronic Opioid Use In New Claims Date of Injury (DOI) 2011 vs IWs with DOIs in 2011 Totals Percent of 2011 total IWs with DOIs in 2013 Totals Percent of 2013 total 2011 vs Percent change IWs that received RX prior to July ,448 IWs that received RX Prior to ,001-29% IWs with "acute" opiate script (RX with 28 days) 4,754 56% IWs with acute opiate script ( RX with 28 days) 3,452 58% -27% IWs with ongoing opiate script (RX after 84 days) 4,483 53% IWs with ongoing opiate script (RX after 84 days) 2,755 46% -39% IWs with acute and ongoing opiate Rx after July ,531 18% IWs with acute and ongoing opiate Rx after July % -44% 6/24/2015 BWC Pharmacy Program Overview 17

18 BWC Opioids Year Total prescribers Total patients Total prescriptions Total drug quantity Average quantity per Rx Average MED per Rx January June ,543 37, ,197 18,277, July December ,720 36, ,005 18,180, January June ,132 35, ,746 17,228, July December ,980 33, ,240 16,192, January June ,563 31, ,583 15,272, July December ,303 29, ,599 14,334, January June ,991 28, ,887 13,518, July December ,880 26, ,790 12,878, January June ,592 25, ,951 12,186, July December ,102 23, ,652 11,161, /24/2015 BWC Pharmacy Program Overview 18

19 Total Ohio Opioids Year Total prescribers Total patients All Ohio Average quantity per Rx All Ohio Average MED per Rx BWC Average quantity per Rx BWC Average MED per Rx January June ,256 1,865, July December ,500 1,908, January June ,148 1,889, July December ,778 1,954, January June ,983 1,978, July December ,671 2,088, January June ,862 1,923, July December ,852 1,918, January June ,769 1,882, Source: Oho Board of Pharmacy 2014 Annual OARRS Report 6/24/2015 BWC Pharmacy Program Overview 19

20 2011 vs 2014 Opioid Dependence (Injured Workers Above 60mg MED/Day) mg MED mg MED mg MED mg MED mg MED > 1000 mg MED 2011 Opiate Dependent IWs 2014 Opiate Dependent IWs 6/24/2015 BWC Pharmacy Program Overview 20

21 Opioid Use By Age of Injured Worker Age ranges IW's per Age Band 2014 IW's per Age Band 163 6/24/2015 BWC Pharmacy Program Overview 21

22 Percentage of Opioid Use By Injured Worker Age Q vs Q % 60.00% 62% 66% 50.00% 40.00% 30.00% 20.00% 10.00% 0.00% 19% 16% 14% 11% 7% 0.04% 4% 1% 0.04% 0.5% Age Band Pct of Total 2014 Age Band Pct of Total 6/24/2015 BWC Pharmacy Program Overview 22

23 Anti-Anxiety Agent Utilization ,000 Injued Workers Receiving Benzodiazepines 70,000 60,000 67,406 65,338 60,821 56,398 50,000 50,211 40,000 30,000 20,000 10,000 10,350 9,912 9,073 8,314 7, /24/2015 BWC Pharmacy Program Overview 23

24 Anti-Anxiety Agent Utilization % 14.0% Percent of IW's with Anti-anxiety Drugs 15.4% 15.2% 14.9% 14.7% 15.5% 12.0% 10.0% 8.0% 6.0% 4.0% 2.0% 0.0% /24/2015 BWC Pharmacy Program Overview 24

25 Benzodiazepine Use By IW Ages /24/2015 BWC Pharmacy Program Overview 25

26 18.00 Avg Daily Anti-Anxiety Drug Load (mg/iw) /24/2015 BWC Pharmacy Program Overview 26

27 Opiates and the Injured Worker Five Ohioans die every day due to unintentional drug poisoning. Between 2006 to 2013, on average, one injured worker died every week due to drug overdose. Ove half of the injured worker drug overdose deaths in 2013 also involved a benzodiazepine An injured worker was over three times more likely to die from drugs than the general population. 20overdose%20data/1finalCB_2012_Bullets%20for%20reporters%20on%20drug%20related%20poisoning.ashx 6/24/2015 BWC Pharmacy Program Overview 27

28 Going Forward o Implement an automated process to identify high risk medication regimens and trigger direct clinical staff contact with the prescriber. o Establish an opioid prescribing rule based on best clinical practices for both prescribing as well as discontinuing these drugs. o Initiate a retail pharmacy based medication therapy management program to coordinate medications in high risk claims. 6/24/2015 BWC Pharmacy Program Overview 28

29 Thank You! Questions?

Opioid epidemic and PEHP

Opioid epidemic and PEHP Opioid epidemic and PEHP Agenda Overview of opioid crisis Utah perspective PEHP: clinical interventions Impact of interventions Why are we here? In the 1990s, the medical establishment came to believe

More information

Combating the Opiate Crisis in Ohio

Combating the Opiate Crisis in Ohio Combating the Opiate Crisis in Ohio In 2011, Gov. John R. Kasich announced the establishment of the Governor s Cabinet Opiate Action Team to fight opiate abuse in Ohio. Ohio is combating drug abuse through

More information

PRESCRIBING GUIDELINES

PRESCRIBING GUIDELINES Ohio Department of Health RESPONSE TO OHIO S PRESCRIPTION DRUG OVERDOSE EPIDEMIC: PRESCRIBING GUIDELINES MIPA CONFERENCE PREVENTING INJURY: FROM RESEARCH TO PRACTICE TO PEOPLE SEPTEMBER 30, 2013 Christy

More information

Curbing Prescription Drug Abuse in Medicaid

Curbing Prescription Drug Abuse in Medicaid Curbing Prescription Drug Abuse in Medicaid Joint Legislative Health Care Oversight Committee October 12, 2010 Dr. Lisa Weeks, BSPharm, PharmD Pharmacy and Ancillary Services Division of Medical Assistance

More information

literature that drug combinations containing butalbital should not be used in treatment of chronic pain and are not appropriate for long term routine

literature that drug combinations containing butalbital should not be used in treatment of chronic pain and are not appropriate for long term routine ACTION: Original BIA p(111397) pa(192459) d: (446870) DATE: 09/16/2013 2:14 PM print date: 04/02/2019 9:58 PM 1. Limit reimbursement for sedative hypnotic agents to the following medications: zolpidem

More information

From heroin to medical marijuana: what districts need to know Megan Greulich, Staff Attorney Hot Topics in School Law October 5, 2016

From heroin to medical marijuana: what districts need to know Megan Greulich, Staff Attorney Hot Topics in School Law October 5, 2016 From heroin to medical marijuana: what districts need to know Megan Greulich, Staff Attorney Hot Topics in School Law October 5, 2016 OSBA leads the way to educational excellence by serving Ohio s public

More information

Summary of Related Documentation Pennsylvania House Bill 1846 of 2014

Summary of Related Documentation Pennsylvania House Bill 1846 of 2014 Summary of Related Documentation Pennsylvania House Bill 1846 of 2014 15 November 2018 Department of Labor & Industry BWC-Administrative Division 1171 S. Cameron St. Harrisburg PA 17104-2501 Essential

More information

Prescription Drug Abuse: Developing Evidence-Based State Level Interventions

Prescription Drug Abuse: Developing Evidence-Based State Level Interventions Prescription Drug Abuse: Developing Evidence-Based State Level Interventions Signe Shackelford, MPH Policy Analyst APHA Annual Meeting November 5, 2013 Presenter Disclosure The following personal financial

More information

NARxCHECK Score as a Predictor of Unintentional Overdose Death

NARxCHECK Score as a Predictor of Unintentional Overdose Death NARxCHECK Score as a Predictor of Unintentional Overdose Death Huizenga J.E., Breneman B.C., Patel V.R., Raz A., Speights D.B. October 2016 Appriss, Inc. NOTE: This paper was previously published with

More information

An Evaluation of the DoD Transdermal Fentanyl Pharmacy Edit. LTC Stacia Spridgen, MSC, USA Director, DoD Pharmacoeconomic Center

An Evaluation of the DoD Transdermal Fentanyl Pharmacy Edit. LTC Stacia Spridgen, MSC, USA Director, DoD Pharmacoeconomic Center An Evaluation of the DoD Transdermal Fentanyl Pharmacy Edit LTC Stacia Spridgen, MSC, USA Director, DoD Pharmacoeconomic Center 1 TRICARE Eligible Beneficiaries Monthly Average, FY08 Retirees & Family

More information

2016 Jurisprudence Update. (Phone) (Fax)

2016 Jurisprudence Update. (Phone) (Fax) 2016 Jurisprudence Update (Phone) 614-466-4143 (Fax) 614-752-4836 www.pharmacy.ohio.gov Goals and Objectives To explain recent law/rule changes which may apply to the pharmacy practice setting. To describe

More information

Building a Comprehensive, Community-driven Prevention Approach to the Opioid Crisis in Maine

Building a Comprehensive, Community-driven Prevention Approach to the Opioid Crisis in Maine Building a Comprehensive, Community-driven Prevention Approach to the Opioid Crisis in Maine Scott M. Gagnon, MPP, PS-C Director, AdCare Educational Institute of Maine, Inc. Co-Chair, Prevention & Harm

More information

Drug Utilization Review & Cost Reduction Strategies. Esther Liu, PharmD, MSIA, CGP Clinical Pharmacist Outcome Resources

Drug Utilization Review & Cost Reduction Strategies. Esther Liu, PharmD, MSIA, CGP Clinical Pharmacist Outcome Resources Drug Utilization Review & Cost Reduction Strategies Esther Liu, PharmD, MSIA, CGP Clinical Pharmacist Outcome Resources Goals and Objectives Define Drug Utilization Reviews Interpret various performance

More information

Na#onal Ins#tute for Health Care Management Founda#on Webinar

Na#onal Ins#tute for Health Care Management Founda#on Webinar Na#onal Ins#tute for Health Care Management Founda#on Webinar Blue Cross Blue Shield of Massachuse=s Opioid Safety Management Program Thomas Kowalski, RPh November 2, 2015 National and Local Concern National

More information

Opiate Use among Ohio Medicaid Recipients

Opiate Use among Ohio Medicaid Recipients Opiate Use among Ohio Medicaid Recipients July 12, 2012 Ohio Colleges of Medicine Government Resource Center The Ohio State University College of Public Health Sponsored by The Ohio Department of Alcohol

More information

October 20, 2016 Scott K. Proescholdbell, MPH. Opioid Overdose and North Carolina s Public Health and Prevention Strategies

October 20, 2016 Scott K. Proescholdbell, MPH. Opioid Overdose and North Carolina s Public Health and Prevention Strategies October 20, 2016 Scott K. Proescholdbell, MPH Opioid Overdose and North Carolina s Public Health and Prevention Strategies Deaths per 100,000 population Death Rates* for Three Selected Causes of Injury,

More information

Michigan Legislative and Regulatory Pharmacy Initiatives Update

Michigan Legislative and Regulatory Pharmacy Initiatives Update Michigan Legislative and Regulatory Pharmacy Initiatives Update Michigan Association of Health Plans Summer Conference Carrie Germain, R.Ph. Health Alliance Plan Senior Director, Pharmacy, Quality and

More information

PBMs: Impact on Cost and Quality of Pharmaceutical Care in the U.S.

PBMs: Impact on Cost and Quality of Pharmaceutical Care in the U.S. Speaker Brian K. Solow, MD, FAAFP Optum Life Sciences Irvine, CA, USA PBMs: Impact on Cost and Quality of Pharmaceutical Care in the U.S. Brian K. Solow, MD, FAAFP Chief Medical Officer, Optum Life Sciences

More information

Medication trends shaping workers compensation. A 2018 update of the prevailing industry influences impacting pharmacy outcomes

Medication trends shaping workers compensation. A 2018 update of the prevailing industry influences impacting pharmacy outcomes Medication trends shaping workers compensation A 2018 update of the prevailing industry influences impacting pharmacy outcomes This page intentionally left blank Trends impacting workers compensation pharmacy

More information

Medicare Part D Opioid Policies for 2019 Information for Patients

Medicare Part D Opioid Policies for 2019 Information for Patients CENTERS FOR MEDICARE & MEDICAID SERVICES Medicare Part D Opioid Policies for 2019 Information for Patients Introduction Prescription opioid pain medications like oxycodone (OxyContin ), hydrocodone (Vicodin

More information

Medicare Part D Prescription Opioid Policies for 2019 Information for Pharmacists

Medicare Part D Prescription Opioid Policies for 2019 Information for Pharmacists CENTERS FOR MEDICARE & MEDICAID SERVICES Medicare Part D Prescription Opioid Policies for 2019 Information for Pharmacists Background Opioid medications are effective at treating certain types of pain,

More information

Opioid Crisis, Our Response Massachusetts Coalition for the Prevention of Medical Errors. October 31, 2016

Opioid Crisis, Our Response Massachusetts Coalition for the Prevention of Medical Errors. October 31, 2016 Opioid Crisis, Our Response Massachusetts Coalition for the Prevention of Medical Errors October 31, 2016 Introduction: The Team Dr. Tony Dodek, Vice President, Medical Quality & Strategy, and Associate

More information

SUBHEAD GOES HERE. Addressing Tennessee s Opioid Crisis. Natalie A. Tate, PharmD Vice President, Pharmacy

SUBHEAD GOES HERE. Addressing Tennessee s Opioid Crisis. Natalie A. Tate, PharmD Vice President, Pharmacy SUBHEAD GOES HERE Addressing Tennessee s Opioid Crisis Natalie A. Tate, PharmD Vice President, Pharmacy Our opioids story Our approach Our response to neonatal abstinence syndrome Facts and faces of opioid

More information

Executive Summary. Classes Under Review: Analysis:

Executive Summary. Classes Under Review: Analysis: Outcome Report on MHQAC Edits Classes Under Review: Analysis: Atypical Antipsychotics, SSRIs, SNRIs, Antianxietals, Hypnotics, and Drugs to Treat ADD/ADHD Utilization and Cost Trends: Pre and Post Implementation

More information

2016 Drug Trends Series

2016 Drug Trends Series Drug Trends Series Part 3: Assessing opioids and compounds Published August 2017 1 Drug Trends Series Opioids & Compounds First Script Introduction As with the first two editions in Coventry s Drug Trends

More information

The Opioid Crisis in Minnesota: On the Ground Approaches. Laura Palombi, PharmD, MPH, MAT, AE-C Heather Blue, PharmD, BCPS, BCGP

The Opioid Crisis in Minnesota: On the Ground Approaches. Laura Palombi, PharmD, MPH, MAT, AE-C Heather Blue, PharmD, BCPS, BCGP The Opioid Crisis in Minnesota: On the Ground Approaches Laura Palombi, PharmD, MPH, MAT, AE-C Heather Blue, PharmD, BCPS, BCGP Objectives Describe current pharmacy practices to address the opioid crisis

More information

Narcotics Monitoring System (NMS) Update

Narcotics Monitoring System (NMS) Update Narcotics Monitoring System (NMS) Update DISCLOSURE OF COMMERCIAL SUPPORT This program has received no financial or in-kind support. Potential for conflict(s) of interest: None Faculty/Presenter Disclosure

More information

Washington State PMP Data Mapping Project

Washington State PMP Data Mapping Project Washington State PMP Data Mapping Project 2014 Category 3 Grant Harold Rogers Category 3 Grantee Meeting February 25, 2015 Washington State BACKGROUND: OPIOID ISSUES AND PLANNING 2 WA Unintentional Opioid

More information

Best Practices in Prescribing Benzodiazepines. Michael Carlisle, DO Medical Director University Hospitals Geauga Medical Center

Best Practices in Prescribing Benzodiazepines. Michael Carlisle, DO Medical Director University Hospitals Geauga Medical Center Best Practices in Prescribing Benzodiazepines Michael Carlisle, DO Medical Director University Hospitals Geauga Medical Center Objectives To review current practice guidelines in benzodiazepine prescribing

More information

Take Home Naloxone: Law Update and Considerations for Pharmacy Professionals

Take Home Naloxone: Law Update and Considerations for Pharmacy Professionals Take Home Naloxone: Law Update and Considerations for Pharmacy Professionals Clint Ross, PharmD, BCPP Clinical Pharmacy Specialist Psychiatry Residency Program Director Psychiatric Pharmacy Medical University

More information

NM DRUG OVERDOSE PREVENTION QUARTERLY MEASURES REPORT FOURTH QUARTER OF 2017 (2017Q4)

NM DRUG OVERDOSE PREVENTION QUARTERLY MEASURES REPORT FOURTH QUARTER OF 2017 (2017Q4) NM DRUG OVERDOSE PREVENTION QUARTERLY MEASURES REPORT FOURTH QUARTER OF 217 () Substance Abuse Epidemiology Section Prescription Drug Overdose Prevention Program Injury and Behavioral Epidemiology Bureau

More information

Managing Narcotics on Workers Comp Claims. Presented By: Craig S. Stern, PharmD, MBA President Pro Pharma Pharmaceutical Consultants, Inc.

Managing Narcotics on Workers Comp Claims. Presented By: Craig S. Stern, PharmD, MBA President Pro Pharma Pharmaceutical Consultants, Inc. Managing Narcotics on Workers Comp Claims Presented By: Craig S. Stern, PharmD, MBA President Pro Pharma Pharmaceutical Consultants, Inc. October 21, 2014 Outline Rationale Scope list drug list Recommended

More information

Opioid Misuse and Overdose Prevention and Safety. Dr. Kathleen Clanon Medical Director May 31, 2018

Opioid Misuse and Overdose Prevention and Safety. Dr. Kathleen Clanon Medical Director May 31, 2018 Opioid Misuse and Overdose Prevention and Safety Dr. Kathleen Clanon Medical Director May 31, 2018 1 On average, 115 Americans die every day from an opioid overdose. Centers for Disease Control 2 Opioid

More information

OHIO S OPIOID DRUG OVERDOSE EPIDEMIC: CONTRIBUTING FACTORS AND ONGOING PREVENTION EFFORTS

OHIO S OPIOID DRUG OVERDOSE EPIDEMIC: CONTRIBUTING FACTORS AND ONGOING PREVENTION EFFORTS OHIO S OPIOID DRUG OVERDOSE EPIDEMIC: CONTRIBUTING FACTORS AND ONGOING PREVENTION EFFORTS DEFINITIONS Opiate- originate from naturally-occurring elements found in the opium poppy plant. These drugs are

More information

2018 Annual Meeting & Educational Conference Opioids In Workers Compensation: Research From WCRI

2018 Annual Meeting & Educational Conference Opioids In Workers Compensation: Research From WCRI 2018 Annual Meeting & Educational Conference Opioids In Workers Compensation: Research From WCRI John W. Ruser, Ph.D. NCSI 2018 Annual Meeting June 12, 2018 AGENDA Introduce WCRI Opioid dispensing to injured

More information

Oregon s PDMP: An epidemiological assist tool

Oregon s PDMP: An epidemiological assist tool Oregon s PDMP: An epidemiological assist tool Todd Beran Center for Prevention and Health Promotion Oregon Health Authority PDMP TTAC Webinar February 13, 2013 1 Acknowledgements Lisa Millet, MSH, Section

More information

Opioid Prescribing Improvement Program

Opioid Prescribing Improvement Program Opioid Prescribing Improvement Program Jeff Schiff, MD, MBA, Medical Director of Minnesota Health Care Programs Sarah Rinn, MPH, Opioid Prescribing Improvement Program Coordinator Agenda Opioid Prescribing

More information

The Opioid Epidemic and How It is Impacting the Workplace. July 24, 2018

The Opioid Epidemic and How It is Impacting the Workplace. July 24, 2018 The Opioid Epidemic and How It is Impacting the Workplace July 24, 2018 In 2016 CDC reports a 300% increase in opioid prescription sales since 1999 without an overall change in reported pain National Safety

More information

View/Enter Patient Record. 3.1 CP-UC1-PS1 Refill Prescription (CASH)

View/Enter Patient Record. 3.1 CP-UC1-PS1 Refill Prescription (CASH) 3 CP-UC1 Dispense Prescription The community pharmacy use case group one (CP-UC1) contains workflows and activities that are focused on the dispensing of a medication to the patient. ID CP-UC1-PS1 CP-UC1-SS1

More information

Shining a Light on MEDs Understanding morphine equivalent dose

Shining a Light on MEDs Understanding morphine equivalent dose Shining a Light on MEDs Understanding morphine equivalent dose In the workers compensation industry, 60.2 percent of claimants utilize opioid analgesics for the treatment of pain caused by a workplace

More information

Prescription Opioid Overdose in Oregon: A public health perspective

Prescription Opioid Overdose in Oregon: A public health perspective Prescription Opioid Overdose in Oregon: A public health perspective Katrina Hedberg, MD, MPH Health Officer & State Epidemiologist Oregon Public Health Division Oregon Health Authority All-Cause Mortality,

More information

The Value of Walgreens

The Value of Walgreens The Value of Walgreens How Walgreens improves employer health plans through access, quality and lower costs Why millions of patients choose Walgreens And your options to move forward with Walgreens Walgreens

More information

Opioid Data for Local Governments in North Carolina

Opioid Data for Local Governments in North Carolina Opioid Data for Local Governments in North Carolina Mary Beth Cox, Stacy Taylor, and Adam Lovelady October 10, 2018 Speakers Adam Lovelady Associate Professor UNC School of Government Mary Beth Cox Substance

More information

Managed Care Pushes for Safer Opioid Oversight

Managed Care Pushes for Safer Opioid Oversight Page 1 of 6 Clinical AUGUST 11, 2017 Managed Care Pushes for Safer Opioid Oversight High-risk pain Rx eyed Denver Health systems haven t escaped the nation s ongoing opioid crisis, as evidenced by surging

More information

ROOM project Addressing the Opioid Epidemic in the U.P. Presented by; Kevin L. Piggott, MD, MPH May 21, 2018

ROOM project Addressing the Opioid Epidemic in the U.P. Presented by; Kevin L. Piggott, MD, MPH May 21, 2018 ROOM project Addressing the Opioid Epidemic in the U.P. Presented by; Kevin L. Piggott, MD, MPH May 21, 2018 REDUCING OPIOID OVERDOSE IN MARQUETTE COUNT Y (ROOM) Funding provided by the CDC to the Michigan

More information

1) Louisiana s Opioid Addiction 2) Adopting a Drug Formulary - HB 592 3) What is the ODG Drug Formulary and How is it Used in Workers Comp 4) The

1) Louisiana s Opioid Addiction 2) Adopting a Drug Formulary - HB 592 3) What is the ODG Drug Formulary and How is it Used in Workers Comp 4) The 1) Louisiana s Opioid Addiction 2) Adopting a Drug Formulary - HB 592 3) What is the ODG Drug Formulary and How is it Used in Workers Comp 4) The Role of Diagnosis (how it will work with the current treatment

More information

Narcotics Safety Initiative opioid overuse, chronic pain, and what Plans can do about it

Narcotics Safety Initiative opioid overuse, chronic pain, and what Plans can do about it Narcotics Safety Initiative opioid overuse, chronic pain, and what Plans can do about it Marcus Thygeson, MD, MPH Chief Health Officer, SVP Healthcare Services Blue Shield of California Celebrities who

More information

Drug-Related Deaths in Ventura County

Drug-Related Deaths in Ventura County ISSUE BRIEFING LOCAL RESEARCH: Drug-Related Deaths in Ventura County 28 24 Kayleigh Hunnicutt, M.A., M.Ed. April 27 OVERVIEW According to data from the Centers for Disease Control and Prevention (CDC),

More information

The Oregon Opioid Initiative. State Pain & Opioid Conference Prescription Drug Monitoring May 2018 Lisa Millet, Public Health Division

The Oregon Opioid Initiative. State Pain & Opioid Conference Prescription Drug Monitoring May 2018 Lisa Millet, Public Health Division The Oregon Opioid Initiative State Pain & Opioid Conference Prescription Drug Monitoring May 2018 Lisa Millet, Public Health Division Disclosure No disclosures 2 Learning Objectives Learner will be able

More information

Prescription Drug Monitoring Program

Prescription Drug Monitoring Program California Department of Justice Prescription Drug Monitoring Program May, 2016 Health and Safety Code section 11165. (a) To assist health care practitioners in their efforts to ensure appropriate prescribing,

More information

Opioid Addiction Statistics

Opioid Addiction Statistics May 2017 Opioid Addiction Statistics Definitions Heroin Epidemic - As pill mills close, prescribing is becoming tighter, demand among younger users rise, and dealer s profits rise, addicts are turning

More information

PHARMACY Section 9. Overview. Preferred Drug List. Additions and Exceptions to the Preferred Drug List

PHARMACY Section 9. Overview. Preferred Drug List. Additions and Exceptions to the Preferred Drug List Overview The management of outpatient prescription drugs is an integral part of the medical management program to improve the health and well-being of our members. Prescriber and member involvement is

More information

Ohio s State Innovation Model: Using Episodes of Care to Impact the Opioid Crisis (and Other Public Health Priorities)

Ohio s State Innovation Model: Using Episodes of Care to Impact the Opioid Crisis (and Other Public Health Priorities) Ohio s State Innovation Model: Using Episodes of Care to Impact the Opioid Crisis (and Other Public Health Priorities) Greg Moody, Director Ohio Governor s Office of Health Transformation NASHP Preconference:

More information

Cynthia B. Jones, Director Department of Medical Assistance Services (DMAS)

Cynthia B. Jones, Director Department of Medical Assistance Services (DMAS) Department of Medical Assistance Services 600 East Broad Street, Suite 1300 Richmond, Virginia 23219 MEDICAID MEMO http://www.dmas.state.va.us TO: All Prescribing Providers, Pharmacists, and Managed Care

More information

Naloxone and Combating the Opioid Epidemic

Naloxone and Combating the Opioid Epidemic Objectives Naloxone and Combating the Opioid Epidemic Jeff Jacobson PharmD Southpointe Pharmacy Discuss the current opioid crisis Define the role of Naloxone in opioid overdose Analyze the barriers to

More information

A nation in pain: Focus on Medicaid

A nation in pain: Focus on Medicaid DATA INSIGHTS A nation in pain: Focus on Medicaid Opioid pain medications have become one of the most controversial classes of prescription therapy. While they provide great benefits in controlling both

More information

Unintentional Drug Poisoning Deaths Dallas County

Unintentional Drug Poisoning Deaths Dallas County Unintentional Drug Poisoning Deaths Dallas County 1997-216 From 1997-216, there were 4498 unintentional poisoning deaths in Dallas County. Unintentional poisoning deaths made up one of every 3.5 unintentional

More information

The Opioid Crisis: Effectiveness of State Responses

The Opioid Crisis: Effectiveness of State Responses The Opioid Crisis: Effectiveness of State Responses Gordon H. Smith, Esq. Maine Medical Association American Society of Medical Association Counsel Mauna Lani Bay, November 2017 Opioids: the difficult

More information

Welcome - we will begin the webinar shortly Please read the participation tips below:

Welcome - we will begin the webinar shortly Please read the participation tips below: Welcome - we will begin the webinar shortly Please read the participation tips below: All guest phones have been muted: Background noises, conversations, white noise etc., can be disruptive to a webinar.

More information

Notice from the Executive Officer: Promoting Compliance with the Existing Limited Use Criteria for Fentanyl Transdermal Patch

Notice from the Executive Officer: Promoting Compliance with the Existing Limited Use Criteria for Fentanyl Transdermal Patch Notice from the Executive Officer: Promoting Compliance with the Existing Limited Use Criteria for Fentanyl Transdermal Patch Frequently Asked Questions 1. What is the new Health Network System feature

More information

Atlanta RIMS March 19, 2015

Atlanta RIMS March 19, 2015 Elements of Good Claims Management for Pain Management Atlanta RIMS March 19, 2015 Ron Warble, Executive Vice President AmeriSys What do you do? Select the Best Answer Call the American Sniper Go see The

More information

Cost-Effective Process to Improve Drug Adherence for Medicare 5-Star

Cost-Effective Process to Improve Drug Adherence for Medicare 5-Star Cost-Effective Process to Improve Drug Adherence for Medicare 5-Star HEALTH ALLIANCE PLAN Presented by Vanita K. Pindolia, Pharm.D. VP, Ambulatory Clinical Pharmacy Programs_PCM Medicare 5-Star Rating

More information

Changing Course: statewide efforts to combat the opioid epidemic in California

Changing Course: statewide efforts to combat the opioid epidemic in California Changing Course: statewide efforts to combat the opioid epidemic in California Kelly Pfeifer, MD kpfeifer@chcf.org April 26, 2018 State of Reform conference STAT Special Report: 52 weeks, 52 faces Obituaries

More information

Montgomery County Poisoning Death Review, 2016: Quarter I Updated June 20, 2016

Montgomery County Poisoning Death Review, 2016: Quarter I Updated June 20, 2016 Montgomery County Poisoning Death Review, 2016: Quarter I Updated June 20, 2016 Prepared by: Robert G. Carlson, Ph.D., Professor and Director, Project Director Linna Li, M.S., Data Manager Raminta Daniulaityte,

More information

2017 NASCSA Conference

2017 NASCSA Conference 2017 NASCSA Conference Drug Trends & Investigations Eric Griffin Director of Compliance & Enforcement Eric.griffin@pharmacy.ohio.gov 614-466-4143 www.pharmacy.ohio.gov Ohio Quick Facts 2006 Ohio established

More information

Taos Alive. Improving a Community in Pain By Julie Martinez CPS

Taos Alive. Improving a Community in Pain By Julie Martinez CPS Taos Alive Improving a Community in Pain By Julie Martinez CPS About Taos County About Taos Alive Community Based Coalition 12 Sectors (Youth, Parents, Business, Media, Schools, Youth Serving Organizations,

More information

Texas Vendor Drug Program Specialty Drug List Process. February 2019

Texas Vendor Drug Program Specialty Drug List Process. February 2019 Texas Vendor Drug Program Specialty Drug List Process February 2019 Table of Contents Table of Contents...1 1 About the Specialty Drug List...2 1.1 Information for Pharmacies... 2 1.2 Information for Managed

More information

Cyber Liability and Crime Update

Cyber Liability and Crime Update Cyber Liability and Crime Update Cyber Liability Probability of a Data Breach 2 3 Cyber Liability Challenges Carriers are not as forthcoming with sharing data as we would like to see Large uptick in ransomware

More information

Best Practices and Foundation Forum. Fred Wells Brason II

Best Practices and Foundation Forum. Fred Wells Brason II Best Practices and Foundation Forum Fred Wells Brason II fbrason@projectlazarus.org Wilkes County, NC Manual labor dominates employment options in this county of 69,000. Wilkes 4 Marvelous M s Moonshine

More information

DPH programs related to opioid use disorder. Judith Martin, MD Medical Director of Substance Use Services SFDPH

DPH programs related to opioid use disorder. Judith Martin, MD Medical Director of Substance Use Services SFDPH DPH programs related to opioid use disorder Judith Martin, MD Medical Director of Substance Use Services SFDPH Opioid safety, SF timeline Opioid agonist treatment: methadone Seven clinics contract with

More information

Shawn A. Ryan, MD, MBA Assistant Professor, Dept. of Emergency Medicine, University of Cincinnati Chair of Quality & Patient Safety, Jewish

Shawn A. Ryan, MD, MBA Assistant Professor, Dept. of Emergency Medicine, University of Cincinnati Chair of Quality & Patient Safety, Jewish Shawn A. Ryan, MD, MBA Assistant Professor, Dept. of Emergency Medicine, University of Cincinnati Chair of Quality & Patient Safety, Jewish Hospital-Mercy Health Partners Addiction Specialist, BrightView

More information

Dispensing and administration of emergency opioid antagonist without a

Dispensing and administration of emergency opioid antagonist without a 68-7-23. Dispensing and administration of emergency opioid antagonist without a prescription. (a) A pharmacist may dispense an FDA-approved emergency opioid antagonist and the necessary medical supplies

More information

Summit County Public Health

Summit County Public Health Page 1 Death and Life Expectancy Summit County Public Health Population Health Vital Statistics Brief: VOLUME 1: DEATH AND LIFE EXPECTANCY Summit County Public Health Population Health Division 1867 W.

More information

Ranked in the top 10% in: -Low percent of adults reporting fair or poor health

Ranked in the top 10% in: -Low percent of adults reporting fair or poor health Marin County ranked in the top 5% in: - Premature death rate - Adults self reported health -Mentally unhealthy days - Adult obesity - Teen birth rate - Uninsured adults - Primary care physicians per capita

More information

The Regional Judicial Opioid Initiative

The Regional Judicial Opioid Initiative Michael L. Buenger Administrative Director Supreme Court of Ohio Columbus, Ohio The Regional Judicial Opioid Initiative 17-305 Table of Contents The Regional Judicial Opioid Initiative PowerPoint Presentation...

More information

Idaho DUR Board Meeting Minutes

Idaho DUR Board Meeting Minutes Idaho DUR Board Meeting Minutes Date: July 20, 2017 Time: 9am-12:30pm Location: Holiday Inn Boise Airport 2970 West Elder Street, Boise, Idaho, 83705 Moderator: David Agler, M.D. Committee Member Present:

More information

Furthermore, medications dispensed by physicians often cost more for the payer than the same medication dispensed by a retail pharmacy.

Furthermore, medications dispensed by physicians often cost more for the payer than the same medication dispensed by a retail pharmacy. Physician Dispensing Physician Dispensing RELEVANCE IN WORKERS COMP Physician dispensing is when prescribers give medications directly to patients, rather than giving patients prescriptions to fill at

More information

Coalition Strategies Across The Continuum of Care

Coalition Strategies Across The Continuum of Care Coalition Strategies Across The Continuum of Care Dorothy J. Chaney M.Ed. CADCA Consultant Building Safe, Healthy, and Drug Free Communities Overview and Objectives: By completing this training participants

More information

Morrison County Community-Based Care Coordination. Our Core Values Reverence Integrity Compassion Excellence

Morrison County Community-Based Care Coordination. Our Core Values Reverence Integrity Compassion Excellence Morrison County Community-Based Care Coordination Our Core Values Reverence Integrity Compassion Excellence Community Based Care Coordination Project The goal is to mitigate the need for, overuse of, and

More information

WA PMP Access by Public Payers. PDMP North Regional Meeting St. Louis, MO April 23-24

WA PMP Access by Public Payers. PDMP North Regional Meeting St. Louis, MO April 23-24 WA PMP Access by Public Payers PDMP North Regional Meeting St. Louis, MO April 23-24 Public Insurer Access PDMP Statute: Allows PDMP data to be provided to Medicaid and Workers Compensation Primary Goal:

More information

Patient Review and Coordination Program

Patient Review and Coordination Program Patient Review and Coordination Program For Medical Assistance Clients Who Need Assistance In Appropriate Use of Phyllis Coolen, RN, MN Division of Healthcare Health and Recovery Administration January

More information

Minimizing Rx Opioid Fraud and Abuse While Maintaining Appropriate Access for Patients In Need. Best Practices for Rx Payers

Minimizing Rx Opioid Fraud and Abuse While Maintaining Appropriate Access for Patients In Need. Best Practices for Rx Payers Minimizing Rx Opioid Fraud and Abuse While Maintaining Appropriate Access for Patients In Need Best Practices for Rx Payers William J. Mahon The MAHON Consulting Group LLC THCI Program on Opioid Risk Management

More information

Creating a Structure for Success: Humboldt Opioid Safety Coalition. Mary Meengs, MD, Medical Director Rosemary DenOuden, Chief Operating Officer

Creating a Structure for Success: Humboldt Opioid Safety Coalition. Mary Meengs, MD, Medical Director Rosemary DenOuden, Chief Operating Officer Creating a Structure for Success: Humboldt Opioid Safety Coalition Mary Meengs, MD, Medical Director Rosemary DenOuden, Chief Operating Officer Behind the Redwood Curtain Remote, sparsely populated 135K

More information

Hospitals Role in Addressing the Opioid Crisis

Hospitals Role in Addressing the Opioid Crisis Hospitals Role in Addressing the Opioid Crisis Webinar 4: Overdose Survivors Outreach Project October 18, 2017 Agenda Overdose Survivors Outreach Project (OSOP) Background Barry Page, Director of Early

More information

9/5/2011. Outline. 1. Past and Current Trends re: RX Abuse 2. Diversion Methods 3. Regulatory Reporting Requirements 4. Q/A

9/5/2011. Outline. 1. Past and Current Trends re: RX Abuse 2. Diversion Methods 3. Regulatory Reporting Requirements 4. Q/A Prescription Drug Abuse Crises Outline 1. Past and Current Trends re: RX Abuse 2. Diversion Methods 3. Regulatory Reporting Requirements 4. Q/A 1 1970s 1980s 2 The 1990s OXYCODONE Oxycodone/APAP OxyContin

More information

Mail Order Is Not For Everyone!

Mail Order Is Not For Everyone! Mail Order Is Not For Everyone! Face to face patient counseling by pharmacists can have a powerful impact on long term health care costs and quality. So, the way health plan sponsors promote mail and generics

More information

COUNTY OF SAN DIEGO. Opioid Update

COUNTY OF SAN DIEGO. Opioid Update COUNTY OF SAN DIEGO Opioid Update Linda Bridgeman Smith, DUI & Prevention Services Manager Health & Human Services Agency, Behavioral Health Services Co-chair, Prescription Drug Abuse Task Force 1 HEADLINES

More information

Amy Larrick Chavez-Valdez, Director, Medicare Drug Benefit and C & D Data Group

Amy Larrick Chavez-Valdez, Director, Medicare Drug Benefit and C & D Data Group DEPARTMENT OF HEALTH & HUMAN SERVICES Centers for Medicare & Medicaid Services 7500 Security Boulevard Baltimore, Maryland 21244-1850 CENTER FOR MEDICARE TO: FROM: SUBJECT: All Part D Sponsors Amy Larrick

More information

Prescription Drug Importation: Can it Help America's Seniors? Safety of Imported Medications: I-SaveRx Case Study

Prescription Drug Importation: Can it Help America's Seniors? Safety of Imported Medications: I-SaveRx Case Study Prescription Drug Importation: Can it Help America's Seniors? Safety of Imported Medications: I-SaveRx Case Study Presented By: Scott McKibbin Special Advocate For Prescription Drugs State Of Illinois

More information

OHIO S PRESCRIPTION DRUG OVERDOSE EPIDEMIC:

OHIO S PRESCRIPTION DRUG OVERDOSE EPIDEMIC: Cuyahoga County Board of Health OHIO S PRESCRIPTION DRUG OVERDOSE EPIDEMIC: NOVEMBER 5, 2014 CONTRIBUTING FACTORS AND ONGOING PREVENTION EFFORTS DEFINITIONS Opiate- originate from naturally-occurring elements

More information

OPQC Learning Session: High Risk Moms & Infants. Mary Applegate, MD, FACP, FAAP Medical Director, Ohio Department of Medicaid September 2016

OPQC Learning Session: High Risk Moms & Infants. Mary Applegate, MD, FACP, FAAP Medical Director, Ohio Department of Medicaid September 2016 OPQC Learning Session: High Risk Moms & Infants Mary Applegate, MD, FACP, FAAP Medical Director, Ohio Department of Medicaid September 2016 OLD: 9/19/2016 2 Collaboration, Cooperation & Coordination Microsystems

More information

Blue Cross of Idaho Addresses State s Opioid Issue

Blue Cross of Idaho Addresses State s Opioid Issue Blue Cross of Idaho Addresses State s Opioid Issue BY THE NUMBERS - Opioid Management page 3 THE PROBLEM - How Preventing Pain Hurt Us page 4 THE SOLUTIONS - Idaho State Board Of Pharmacy Prescription

More information

Opioids: What You Should Know About Opioid Prescribing. Denis G. Patterson, DO Nevada State Medical Association October 19, 2016

Opioids: What You Should Know About Opioid Prescribing. Denis G. Patterson, DO Nevada State Medical Association October 19, 2016 Opioids: What You Should Know About Opioid Prescribing Denis G. Patterson, DO Nevada State Medical Association October 19, 2016 Contact Information Denis G. Patterson, DO Nevada Advanced Pain Specialists

More information

New Medicare Part D Prescription Opioid Policies for 2019 Information for Prescribers

New Medicare Part D Prescription Opioid Policies for 2019 Information for Prescribers CENTERS FOR MEDICARE & MEDICAID SERVICES New Medicare Part D Prescription Opioid Policies for 2019 Information for Prescribers Background CMS understands the magnitude of the nation s opioid epidemic and

More information

The Impact of the Opioid Crisis. Deborah A. McMahan, MD Health Commissioner Allen County Department of Health

The Impact of the Opioid Crisis. Deborah A. McMahan, MD Health Commissioner Allen County Department of Health The Impact of the Opioid Crisis Deborah A. McMahan, MD Health Commissioner Allen County Department of Health Agenda How This Mess Started Scope of the Problem Why We Should Care -- Impact How This Mess

More information

2017 Drug Trends Series

2017 Drug Trends Series 2017 Drug Trends Series Part 1 Evaluating the traditional view Retail and mail-order prescriptions Published April 2018 1 2017 Drug Trends Series Traditional View First Script A year of important progress

More information

Medicaid Expansion: Its Critical Role in Ohio s Response to the Addiction Crisis

Medicaid Expansion: Its Critical Role in Ohio s Response to the Addiction Crisis Medicaid Expansion: Its Critical Role in Ohio s Response to the Addiction Crisis 1 Medicaid Expansion: Its Critical Role in Ohio s Response to the Addiction Crisis Ohio expanded Medicaid in 2014 to provide

More information

Reducing Opioid Deaths: Arizona s Emergency Declaration & Response

Reducing Opioid Deaths: Arizona s Emergency Declaration & Response Reducing Opioid Deaths: Arizona s Emergency Declaration & Response September 15, 2017 Sheila Sjolander, Assistant Director Arizona Department of Health Services Emergency Declaration On June 5, 2017, Arizona

More information

Buprenorphine Order Set and Rapid Access Referral. Copyright 2017, CAMH

Buprenorphine Order Set and Rapid Access Referral. Copyright 2017, CAMH 2 Buprenorphine Order Set and Rapid Access Referral 1 Agenda Problem Identification / Identification Importance / Importance Baseline Workflow Baseline Workflow Baseline Data Baseline Data Objectives Solution

More information

Population Health Vital Statistics Brief:

Population Health Vital Statistics Brief: Page 1 Death and Life Expectancy Summit County Public Health Population Health Vital Statistics Brief: VOLUME 1: DEATH AND LIFE EXPECTANCY Summit County Public Health Populaon Health Division 1867 W. Market

More information